Ovoca Bio (OVB) Competitors GBX 1.29 +0.04 (+2.96%) As of 09:51 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock OVB vs. APTA, GENF, EVG, MTFB, DEST, ROQ, VAL, RENE, NFX, and SALVShould you be buying Ovoca Bio stock or one of its competitors? The main competitors of Ovoca Bio include Aptamer Group (APTA), Genflow Biosciences (GENF), Evgen Pharma (EVG), Motif Bio (MTFB), Destiny Pharma (DEST), Roquefort Therapeutics (ROQ), ValiRx (VAL), ReNeuron Group (RENE), Nuformix (NFX), and SalvaRx Group (SALV). These companies are all part of the "biotechnology" industry. Ovoca Bio vs. Aptamer Group Genflow Biosciences Evgen Pharma Motif Bio Destiny Pharma Roquefort Therapeutics ValiRx ReNeuron Group Nuformix SalvaRx Group Aptamer Group (LON:APTA) and Ovoca Bio (LON:OVB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking. Does the media favor APTA or OVB? In the previous week, Aptamer Group's average media sentiment score of 0.00 equaled Ovoca Bio'saverage media sentiment score. Company Overall Sentiment Aptamer Group Neutral Ovoca Bio Neutral Does the MarketBeat Community believe in APTA or OVB? Ovoca Bio received 17 more outperform votes than Aptamer Group when rated by MarketBeat users. CompanyUnderperformOutperformAptamer GroupN/AN/AOvoca BioOutperform Votes1770.83% Underperform Votes729.17% Which has more volatility & risk, APTA or OVB? Aptamer Group has a beta of -0.52, suggesting that its stock price is 152% less volatile than the S&P 500. Comparatively, Ovoca Bio has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Do institutionals & insiders have more ownership in APTA or OVB? 11.7% of Aptamer Group shares are owned by institutional investors. 13.2% of Aptamer Group shares are owned by insiders. Comparatively, 44.7% of Ovoca Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has preferable earnings and valuation, APTA or OVB? Ovoca Bio has lower revenue, but higher earnings than Aptamer Group. Ovoca Bio is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptamer Group£4.12M1.34-£14.17M-£0.71-0.39Ovoca BioN/AN/A-£1.35M-£1.09-1.19 Is APTA or OVB more profitable? Ovoca Bio has a net margin of 0.00% compared to Aptamer Group's net margin of -343.95%. Ovoca Bio's return on equity of -52.49% beat Aptamer Group's return on equity.Company Net Margins Return on Equity Return on Assets Aptamer Group-343.95% -205.63% -44.96% Ovoca Bio N/A -52.49%3.70% SummaryOvoca Bio beats Aptamer Group on 7 of the 11 factors compared between the two stocks. Get Ovoca Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OVB and its competitors with MarketBeat's FREE daily newsletter. Email Address OVB vs. The Competition Export to ExcelMetricOvoca BioBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.30M£120.67M£5.42B£2.52BDividend Yield0.83%3.69%5.44%4.96%P/E Ratio-1.193.0022.25131.73Price / SalesN/A4,182.14397.52238,268.04Price / Cash1.0013.0238.2028.02Price / Book0.5334.576.834.47Net Income-£1.35M-£90.45M£3.21B£5.81B7 Day Performance-0.16%1.37%5.52%1.56%1 Month Performance-8.07%-3.84%-5.77%5.40%1 Year Performance46.92%89.57%16.66%101.20% Ovoca Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OVBOvoca BioN/AGBX 1.29+3.0%N/A+93.8%£1.30MN/A-1.195High Trading VolumeAPTAAptamer GroupN/AGBX 0.26flatN/A-65.5%£5.17M£4.12M-0.3637GENFGenflow BiosciencesN/AGBX 1.02-0.9%N/A-27.5%£3.46M£-226,187.99-1.925High Trading VolumeEVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010MTFBMotif BioN/AN/AN/AN/A£3.28MN/A-0.036DESTDestiny PharmaN/AN/AN/AN/A£2.87M£135,028.00-50.0024News CoverageGap DownHigh Trading VolumeROQRoquefort TherapeuticsN/AGBX 1.71-7.4%N/A-61.5%£2.18M£2,662.35-1.419Gap DownVALValiRxN/AGBX 0.52+4.8%N/A-85.0%£1.99M£27,777.32-0.355,450Gap DownRENEReNeuron GroupN/AN/AN/AN/A£1.93M£783,000.00-37.502Gap DownNFXNuformix1.1968 of 5 starsGBX 0.14+5.3%GBX 293+209,185.7%-46.3%£1.73MN/A-4.253Gap DownSALVSalvaRx GroupN/AN/AN/AN/A£1.65M£64.50M0.032Gap Up Related Companies and Tools Related Companies APTA Alternatives GENF Alternatives EVG Alternatives MTFB Alternatives DEST Alternatives ROQ Alternatives VAL Alternatives RENE Alternatives NFX Alternatives SALV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:OVB) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovoca Bio plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovoca Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OVB Stock Free OVB Stock Alerts